Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -282,573 | -185,135 | -100,207 | 397,555 | 485,866 |
| Depreciation Amortization | 3,315 | 1,620 | 686 | -2,395 | -2,584 |
| Income taxes - deferred | N/A | N/A | N/A | 110,333 | 110,333 |
| Accounts receivable | 1,766 | 1,759 | 1,498 | 3,432 | 3,390 |
| Other Working Capital | -6,420 | -15,131 | -9,760 | 6,208 | -3,290 |
| Other Operating Activity | 37,201 | 25,089 | 13,738 | 53,561 | 36,407 |
| Operating Cash Flow | $-246,711 | $-171,798 | $-94,045 | $568,694 | $630,122 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -684 | -562 | -532 | -4,819 | -2,933 |
| Purchase Of Investment | -641,445 | -462,724 | -182,794 | -1,469,220 | -1,248,644 |
| Sale Of Investment | 767,434 | 616,289 | 222,235 | 976,093 | 619,441 |
| Other Investing Activity | 0 | 0 | 0 | 997 | 997 |
| Investing Cash Flow | $125,305 | $153,003 | $38,909 | $-496,949 | $-631,139 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,810 | -1,829 | -887 | -3,282 | -2,416 |
| Common Stock Issued | 341,019 | 327,509 | 3,191 | 13,147 | 12,688 |
| Financing Cash Flow | $338,209 | $325,680 | $2,304 | $9,865 | $10,272 |
| Exchange Rate Effect | 68 | 17 | -14 | -10 | -45 |
| Beginning Cash Position | 243,500 | 243,500 | 243,500 | 161,900 | 161,900 |
| End Cash Position | 460,371 | 550,402 | 190,654 | 243,500 | 171,110 |
| Net Cash Flow | $216,871 | $306,902 | $-52,846 | $81,600 | $9,210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -246,711 | -171,798 | -94,045 | 568,694 | 630,122 |
| Capital Expenditure | -684 | -562 | -532 | -4,819 | -2,933 |
| Free Cash Flow | -247,395 | -172,360 | -94,577 | 563,875 | 627,189 |